Dr. Ferrajoli is an Academic Hematologist/Oncologist practicing in the Leukemia Department at the University of Texas, MD Anderson since 1998. Her main area of interest includes the treatment and  Biology of Chronic  Lymphocytic Leukemia and its variants, and treatment of elderly patients with Acute and Chronic Leukemia. In these fields Dr. Ferrajoli has authored and co-authored more than two hundred and fifty publications in peer reviewed journals. Dr. Ferrajoli serves on numerous journal editorial boards and grant proposal study sessions for several US and European Agencies. Dr. Ferrajoli is a member of professional societies such the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO), International Society of Geriatric Oncology (SIOG), the European Society for Medical Oncology (ESMO) and the European Hematology Association (EHA).